Literature DB >> 8616774

The identification of febrile, neutropenic children with neoplastic disease at low risk for bacteremia and complications of sepsis.

K G Lucas1, A E Brown, D Armstrong, D Chapman, G Heller.   

Abstract

BACKGROUND: The management of pediatric oncology patients with fever and neutropenia assumes that all patients are at risk for bacteremia, and therefore generally involves hospitalization and broad-spectrum parenteral antibiotics for all patients. The determination of which patients are at low risk for having positive blood cultures and for developing complications related to bacteremia is of potential benefit.
METHODS: The records of 161 pediatric patients with neoplastic disease hospitalized for 509 episodes of fever and neutropenia between January 1990 and June 1992 were retrospectively reviewed. Clinical features at initial presentation, clinical and microbiologic documentation of infection, and outcome were analyzed.
RESULTS: The only presenting clinical features that correlated with an increased likelihood of having positive blood cultures were chills, hypotension, the requirement for fluid resuscitation (P < 0.001), or a diagnosis of leukemia or lymphoma (P < 0.041). Leukemia patients with relapse admitted for fever and neutropenia were no more likely to have positive blood cultures than those patients in remission. There were ten episodes of fever and neutropenia in which patients were transferred to the intensive care unit (ICU), and two sepsis related deaths. Nine episodes involving ICU management and both deaths were in patients who had persistent fever and an absolute neutrophil count (ANC) of less than 100 after 48 hours of hospitalization (n = 177). Patients with an ANC of less than 100 after 48 hours were twice as likely to have antibiotic changes, 15 times more likely to receive amphotericin B, and were hospitalized twice as long as patients with an ANC of 100 or higher after 48 hours.
CONCLUSIONS: Children hospitalized for fever and neutropenia who have persistent fever and an ANC of less than 100 after 48 hours are at high risk for morbidity and are more likely to require antibiotic changes and antifungal therapy. Children who initially lack signs of sepsis, are afebrile, and have an ANC of 100 or higher after 48 hours are at low risk for complications and could be selectively discharged on antimicrobials after a 48-hour period of inpatient hospitalization.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8616774

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  26 in total

1.  [Bacteraemia risk criteria in the paediatric febrile neutropenic cancer patient].

Authors:  Sandra Gala Peralta; Teresa Cardesa Salzman; Juan José García García; Jesús Estella Aguado; Amadeu Gené Giralt; Carles Luaces Cubells
Journal:  Clin Transl Oncol       Date:  2005-05       Impact factor: 3.405

Review 2.  Haemopoietic growth factors in paediatric oncology: a review of the literature.

Authors:  L M Wagner; W L Furman
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 3.  Outpatient therapy for febrile neutropenia: clinical and economic implications.

Authors:  Fausto de Lalla
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

4.  An analysis of interleukin-8, interleukin-6 and C-reactive protein serum concentrations to predict fever, gram-negative bacteremia and complicated infection in neutropenic cancer patients.

Authors:  A Engel; E Mack; P Kern; W V Kern
Journal:  Infection       Date:  1998 Jul-Aug       Impact factor: 3.553

Review 5.  Outpatient management of febrile neutropenia in children with cancer.

Authors:  Mark Holdsworth; Jeff Hanrahan; Bernadette Albanese; Jami Frost
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

6.  Fever in neutropenia in children and adolescents: evolution over time of main characteristics in a single center, 1993-2001.

Authors:  Roland A Ammann; Christoph Aebi; Andreas Hirt; Annette Ridolfi Lüthy
Journal:  Support Care Cancer       Date:  2004-07-08       Impact factor: 3.603

7.  Prognostic factors influencing infection-related mortality in patients with acute leukemia in Korea.

Authors:  Jin-Hong Yoo; Su Mi Choi; Dong-Gun Lee; Jung-Hyun Choi; Wan-Shik Shin; Woo-Sung Min; Chun-Choo Kim
Journal:  J Korean Med Sci       Date:  2005-02       Impact factor: 2.153

Review 8.  Rethinking Antimicrobial Prophylaxis in the Transplant Patient in the World of Emerging Resistant Organisms-Where Are We Today?

Authors:  Lucy E Horton; Nina M Haste; Randy A Taplitz
Journal:  Curr Hematol Malig Rep       Date:  2018-02       Impact factor: 3.952

9.  Repeating blood cultures in neutropenic children with persistent fevers when the initial blood culture is negative.

Authors:  Jeremy Rosenblum; Juan Lin; Mimi Kim; Adam S Levy
Journal:  Pediatr Blood Cancer       Date:  2012-10-09       Impact factor: 3.167

Review 10.  Hyperpyrexia and high fever as a predictor for serious bacterial infection (SBI) in children-a systematic review.

Authors:  Noa Rosenfeld-Yehoshua; Shiri Barkan; Ibrahim Abu-Kishk; Meirav Booch; Ruth Suhami; Eran Kozer
Journal:  Eur J Pediatr       Date:  2018-01-31       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.